Lataa...
Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study
BACKGROUND AND AIM: Peroxisome proliferator-activated receptor-γ (PPAR-γ) modulating treatment may have cardiovascular benefits in type 2 diabetes mellitus (T2DM) patients after ischemic stroke (IS). However, whether there are additional benefits from intensive PPAR-γ modulating treatments in Asian...
Tallennettuna:
| Julkaisussa: | Cardiovasc Diabetol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945719/ https://ncbi.nlm.nih.gov/pubmed/31910836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0979-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|